{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T02:06:43Z","timestamp":1778810803171,"version":"3.51.4"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:00:00Z","timestamp":1760054400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Non-melanoma skin cancers (NMSCs) are the most common neoplasms that occur in solid organ transplant recipients (SOTRs). Squamous cell carcinoma (SCC) and basal cell carcinoma (BCC) make up over 90% of skin cancers in SOTRs. Key risk factors include age at transplantation, skin type, immunosuppression, as well as sun exposure (ultraviolet radiation) and viral infections, contributing significantly to tumor development. This study aimed to estimate the incidence and risk of NMSCs in kidney transplant recipients (KTRs) in Poland and to provide new clinical data on patients developing skin cancers in this population.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This study included 105 KTRs, out of approximately 1,500, who were under the care of the Transplant Outpatient Clinic at the University Hospital in Gdansk between 1980 and 2022 and were diagnosed with NMSC.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 250 cutaneous malignancies were diagnosed in 105 KTRs. BCC (58.8%) and SCC (37.6%) were the most common histological types, and the SCC: BCC ratio was approximately 2:3. Other skin neoplasms, including malignant melanoma (2%) or hidradenocarcinoma, were significantly less frequent. The mean age of KTRs at the time of skin cancer diagnosis was 59.6 years, with a mean time from transplantation to cancer diagnosis of 103.2 months. Most skin cancers were diagnosed 5\u201310 years post-transplantation and were located on the.24%). The immunosuppressive therapy protocol did not significantly affect the risk of developing skin cancer. The only significant factor associated with an increased risk of skin cancer was patient age. One patient died due to metastatic SCC.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>NMSCs account for 90% of skin cancers in KTRs; they have a high recurrence rate and are most often found on the face of older patients towards the end of the first decade after transplantation. Our study confirms that the risk of further skin neoplasm is high and that SCC can be a cause of death. Early detection not only improves prognosis but also minimizes the extent of surgical interventions, which is particularly crucial for lesions in visible areas.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2025.1636411","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T04:20:15Z","timestamp":1760070015000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Prevalence of skin cancers in kidney transplant recipients - one-center experience"],"prefix":"10.3389","volume":"15","author":[{"given":"Fabian","family":"Kosko","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicja","family":"D\u0119bska-\u015alizie\u0144","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beata","family":"Imko-Walczuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Luiza","family":"Piesiak\u00f3w","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bogdan","family":"Biedunkiewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Bu\u0142\u0142o-Piontecka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beata","family":"Bzoma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrzej","family":"Chamienia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justyna","family":"Go\u0142\u0119biewska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"Konopa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewa","family":"Kr\u00f3l","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomasz","family":"Liberek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Lichodziejewska-Niemierko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u0142awomir","family":"Lizakowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Przemys\u0142aw","family":"Rutkowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnieszka","family":"Tarasewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcin","family":"Wczysla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zbigniew","family":"Heleniak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra022137","article-title":"Skin cancers after organ transplantation","volume":"348","author":"Euvrard","year":"2003","journal-title":"N Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2017.0045","article-title":"Comparison of posttransplant dermatologic diseases by race","volume":"153","author":"Chung","year":"2017","journal-title":"JAMA Dermatol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.det.2011.02.004","article-title":"Management of skin cancer in solid-organ transplant recipients: A multidisciplinary approach","volume":"29","author":"Greenberg","year":"2011","journal-title":"Dermatol Clin"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.hoc.2018.08.001","article-title":"Cutaneous squamous cell carcinoma","volume":"33","author":"Waldman","year":"2019","journal-title":"Hematol Oncol Clin North Am"},{"key":"B5","article-title":"Basal Cell Carcinoma","volume-title":"StatPearls","author":"McDaniel","year":"2023"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2000.8290","article-title":"Clinical risk factors associated with nonmelanoma skin cancer in renal transplant recipients","volume":"36","author":"Ramsay","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1155\/2007\/942650","article-title":"Human papillomaviruses and non-melanoma skin cancer: basic virology and clinical manifestations","volume":"23","author":"Nindl","year":"2007","journal-title":"Dis Markers"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1097\/01.tp.0000186382.81130.ba","article-title":"Malignancy after transplantation","volume":"80","author":"Buell","year":"2005","journal-title":"Transplantation"},{"key":"B9","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1097\/01.TP.0000081399.75231.3B","article-title":"Tacrolimus enhances transforming growth factor-beta1 expression and promotes tumor progression","volume":"76","author":"Maluccio","year":"2003","journal-title":"Transplantation"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1126\/science.273.5278.1109","article-title":"Role of postreplicative DNA mismatch repair in the cytotoxic action of thioguanine","volume":"273","author":"Swann","year":"1996","journal-title":"Science"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.5114\/ada.2023.127637","article-title":"Non-melanoma skin cancer outcomes in kidney transplant recipients converted from calcineurin inhibitors to mTOR inhibitors: a systematic review","volume":"40","author":"Olszewska","year":"2023","journal-title":"Postepy Dermatol Alergol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.13105\/wjma.v11.i7.317","article-title":"Post-transplant Malignancy: Focusing on virus-associated etiologies, pathogenesis, evidence-based management algorithms, present status of adoptive immunotherapy and future directions","volume":"11","author":"Yadav","year":"2023","journal-title":"World J Meta-Anal"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2009.02997.x","article-title":"Switch to a sirolimus-based immunosuppression in long-term renal transplant recipients: reduced rate of (pre-)malignancies and nonmelanoma skin cancer in a prospective, randomized, assessor-blinded, controlled clinical trial","volume":"10","author":"Salgo","year":"2010","journal-title":"Am J Transplant"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2016.11.008","article-title":"The risk of cancer in kidney transplant recipients may be reduced in those maintained on everolimus and reduced cyclosporine","volume":"91","author":"Lim","year":"2017","journal-title":"Kidney Int"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g6679","article-title":"Effect of sirolimus on Malignancy and survival after kidney transplantation: systematic review and meta-analysis of individual patient data","volume":"349","author":"Knoll","year":"2014","journal-title":"BMJ"},{"key":"B16","doi-asserted-by":"crossref","DOI":"10.6004\/jnccn.2021.0059","article-title":"NCCN Guidelines\u00ae Insights: Squamous Cell Skin Cancer, Version 1.2022","volume":"19","author":"Schmults","year":"2021","journal-title":"J Natl Compr Canc Netw"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2024.01.040","article-title":"Cumulative incidence and risk factors for cutaneous squamous cell carcinoma metastases in organ transplant recipients: The Skin Care in Organ Transplant Patients in Europe-International Transplant Skin Cancer Collaborative metastases study, a prospective multicenter study","volume":"90","author":"de Jong","year":"2024","journal-title":"J Am Acad Dermatol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.1592","article-title":"Spectrum of cancer risk among US solid organ transplant recipients","volume":"306","author":"Engels","year":"2011","journal-title":"JAMA"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1097\/01.tp.0000184006.43152.8d","article-title":"Maintenance immunosuppression with target-of-rapamycin inhibitors is associated with a reduced incidence of de novo Malignancies","volume":"80","author":"Kauffman","year":"2005","journal-title":"Transplantation"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2005090993","article-title":"Sirolimus therapy after early cyclosporine withdrawal reduces the risk for cancer in adult renal transplantation","volume":"17","author":"Campistol","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S78456","article-title":"Non-melanoma skin cancer in renal transplant recipients: a study in a Brazilian reference center","volume":"8","author":"Gon\u00e7alves","year":"2015","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2002.04976.x","article-title":"Non-melanoma skin cancer risk in the Queensland renal transplant population","volume":"147","author":"Ramsay","year":"2002","journal-title":"Br J Dermatol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.5507\/bp.2010.039","article-title":"Skin cancer incidence in renal transplant recipients - a single center study","volume":"154","author":"Kalinova","year":"2010","journal-title":"BioMed Pap Med Fac Univ Palacky Olomouc Czech Repub"},{"key":"B24","article-title":"The Burden of Skin Diseases [BOSD] in Europe: Preliminaryresults about skin cancers diagnosis and care pathway","volume-title":"EADV Abstracts Book 2022: EADV Spring Symposium \u2013 Ljubljana, 12-14 May 2022","author":"Richard","year":"2022"},{"key":"B25","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s13555-016-0165-y","article-title":"Skin cancer: epidemiology, disease burden, pathophysiology, diagnosis, and therapeutic approaches","volume":"7","author":"Apalla","year":"2017","journal-title":"Dermatol Ther (Heidelb)"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000005056","article-title":"Cancer surveillance in solid organ transplant recipients with a pretransplant history of Malignancy: multidisciplinary collaborative expert opinion","volume":"108","author":"Watt","year":"2024","journal-title":"Transplantation"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2021.3180","article-title":"Consensus-based recommendations on the prevention of squamous cell carcinoma in solid organ transplant recipients: A delphi consensus statement","volume":"157","author":"Massey","year":"2021","journal-title":"JAMA Dermatol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.2004.30150.x","article-title":"International Transplant-Skin Cancer Collaborative; European Skin Care in Organ Transplant Patients Network. Guidelines for the management of squamous cell carcinoma in organ transplant recipients","volume":"30","author":"Stasko","year":"2004","journal-title":"Dermatol Surg"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1636411\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T04:20:16Z","timestamp":1760070016000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1636411\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,10]]},"references-count":28,"alternative-id":["10.3389\/fonc.2025.1636411"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1636411","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,10]]},"article-number":"1636411"}}